Want to see NL:PHARM full AI Analyst Report?
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 376.13M | $ 297.07M | $ 245.32M | $ 205.62M | $ 198.87M |
| Gross Profit | $ 330.63M | $ 261.80M | $ 220.10M | $ 188.06M | $ 165.73M |
| Operating Income | $ 20.88M | $ -3.67M | $ -4.88M | $ 18.23M | $ 19.01M |
| EBITDA | $ 34.78M | $ 13.65M | $ 9.88M | $ 33.53M | $ 55.30M |
| Net Income | $ 2.97M | $ -11.84M | $ -10.55M | $ 13.67M | $ 15.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 179.88M | $ 167.82M | $ 213.42M | $ 208.58M | $ 191.92M |
| Total Assets | $ 500.02M | $ 400.61M | $ 462.85M | $ 425.80M | $ 397.42M |
| Total Debt | $ 115.79M | $ 112.26M | $ 171.54M | $ 167.69M | $ 161.76M |
| Net Debt | $ -30.29M | $ 57.34M | $ 109.80M | $ -40.89M | $ -29.41M |
| Total Liabilities | $ 222.89M | $ 178.85M | $ 244.07M | $ 221.16M | $ 204.45M |
| Stockholders' Equity | $ 277.10M | $ 221.76M | $ 218.78M | $ 204.64M | $ 192.92M |
| Cash Flow | |||||
| Free Cash Flow | $ 51.18M | $ -2.58M | $ -18.77M | $ 20.92M | $ 22.86M |
| Operating Cash Flow | $ 51.96M | $ -1.79M | $ -17.30M | $ 22.90M | $ 31.58M |
| Investing Cash Flow | $ 19.13M | $ 32.74M | $ -129.39M | $ 5.32M | $ -23.06M |
| Financing Cash Flow | $ 15.03M | $ -35.63M | $ -1.04M | $ -4.98M | $ -22.54M |